| # | Drug | Count |
|---|---|---|
| 0 | MEGNESIUM OXIDE | 2 |
| 1 | ACETAMINOPHEN | 1 |
| 2 | ACETAMINOPHEN 500MG | 1 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 4 | ALBUTEROL | 1 |
| 5 | ALBUTEROL SULFATE | 1 |
| 6 | AMLODIPINE | 1 |
| 7 | CALCIUM | 1 |
| 8 | CONJUGATED ESTROGENS | 1 |
| 9 | DIAZEPAM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEGNESIUM OXIDE | 2 | 0.0048 |
| 1 | FLECAINIDE ACETATE | 1 | 0.0002 |
| 2 | PROGESTERONE | 1 | 0.0000 |
| 3 | TAPENTADOL HYDROCHLORIDE | 1 | 0.0000 |
| 4 | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0000 |
| 5 | DOCUSATE SODIUM | 1 | 0.0000 |
| 6 | CONJUGATED ESTROGENS | 1 | 0.0000 |
| 7 | ESTROGENS, CONJUGATED | 1 | 0.0000 |
| 8 | GLATIRAMER ACETATE | 1 | 0.0000 |
| 9 | LIDOCAINE HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Opioid Agonist [EPC] | 2 |
| 1 | Benzodiazepine [EPC] | 1 |
| 2 | Calcium Channel Blocker [EPC] | 1 |
| 3 | Calcium [EPC] | 1 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 |
| 5 | Estrogen [EPC] | 1 |
| 6 | GLP-1 Receptor Agonist [EPC] | 1 |
| 7 | Janus Kinase Inhibitor [EPC] | 1 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| 9 | Progesterone [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progesterone [EPC] | 1 | 0.0000 |
| 1 | Opioid Agonist [EPC] | 2 | 0.0000 |
| 2 | Calcium [EPC] | 1 | 0.0000 |
| 3 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Estrogen [EPC] | 1 | 0.0000 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 6 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | Benzodiazepine [EPC] | 1 | 0.0000 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |